US5505941A
(en)
*
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
US5833975A
(en)
*
|
1989-03-08 |
1998-11-10 |
Virogenetics Corporation |
Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
|
US5174993A
(en)
*
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
US4603112A
(en)
*
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
US5110587A
(en)
*
|
1981-12-24 |
1992-05-05 |
Health Research, Incorporated |
Immunogenic composition comprising synthetically modified vaccinia virus
|
US7767449B1
(en)
|
1981-12-24 |
2010-08-03 |
Health Research Incorporated |
Methods using modified vaccinia virus
|
US5338683A
(en)
*
|
1981-12-24 |
1994-08-16 |
Health Research Incorporated |
Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
|
WO1984002077A1
(en)
*
|
1982-11-30 |
1984-06-07 |
Us Health |
Process for producing poxvirus recombinants for expression of foreign genes
|
US7045313B1
(en)
|
1982-11-30 |
2006-05-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA
|
US5866383A
(en)
*
|
1982-11-30 |
1999-02-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
In vitro ligation of foreign DNA into large eukaryotic viruses
|
US5338674A
(en)
*
|
1983-02-25 |
1994-08-16 |
Wright Stephen E |
Process for producing a vaccine for a pathogenic RNA virus and product thereof
|
FR2563434B1
(fr)
*
|
1984-04-25 |
1986-07-25 |
Transgene Sa |
Vaccin contre la rage et procede pour sa preparation
|
US5830477A
(en)
*
|
1984-04-25 |
1998-11-03 |
Transgene S.A. |
Vaccine against rabies and process for preparation thereof
|
DE3576360D1
(de)
*
|
1984-05-22 |
1990-04-12 |
Transgene Sa |
Expressionsvektoren fuer faktor ix und aktionsfaktor ix produzierende zellinien.
|
US4859587A
(en)
*
|
1984-06-04 |
1989-08-22 |
Institut Merieux |
Recombinant herpes simplex viruses, vaccines and methods
|
US5288641A
(en)
*
|
1984-06-04 |
1994-02-22 |
Arch Development Corporation |
Herpes Simplex virus as a vector
|
CA1282721C
(en)
*
|
1984-06-04 |
1991-04-09 |
Bernard Roizman |
Herpes simplex virus as a vector
|
US4738846A
(en)
*
|
1984-08-30 |
1988-04-19 |
The Salk Institute For Biological Studies |
Vaccine for vesicular stomatitis virus
|
FR2571060B1
(fr)
*
|
1984-10-03 |
1987-01-09 |
Centre Nat Rech Scient |
Nouveaux vecteurs de clonage et d'expression dans les cellules eucaryotes utilisant le virus de la vaccine
|
GB8508845D0
(en)
*
|
1985-04-04 |
1985-05-09 |
Hoffmann La Roche |
Vaccinia dna
|
EP0263207B1
(de)
*
|
1986-10-08 |
1991-11-27 |
The Upjohn Company |
Virus-Vakzin
|
US5275934A
(en)
*
|
1985-07-29 |
1994-01-04 |
The Upjohn Company |
Method of detecting viral infection in vaccinated animals
|
US5128128A
(en)
*
|
1985-07-29 |
1992-07-07 |
The Upjohn Company |
Virus vaccine
|
KR950000887B1
(ko)
*
|
1985-07-29 |
1995-02-03 |
디 엎죤 캄파니 |
프로제니터 비루스 왁찐 조성물, 이의 제조방법, 및 이를 사용하여 비루스에 감염된 동물과 왁찐 주사를 맞은 동물을 구별하기 위한 방법
|
IL79880A0
(en)
*
|
1985-08-29 |
1986-11-30 |
Inst Medical W & E Hall |
Recombinant virus
|
US5352575A
(en)
*
|
1985-10-04 |
1994-10-04 |
The Upjohn Company |
Pseudorabies virus protein
|
US6251634B1
(en)
|
1985-11-26 |
2001-06-26 |
Pharmacia & Upjohn Company |
Pseudorabies virus protein
|
AU602875B2
(en)
*
|
1985-12-18 |
1990-11-01 |
British Technology Group Limited |
Newcastle disease virus gene clones
|
US5262177A
(en)
*
|
1986-02-07 |
1993-11-16 |
Oncogen |
Recombinant viruses encoding the human melanoma-associated antigen
|
IL82104A0
(en)
*
|
1986-04-08 |
1987-10-30 |
Usa |
Recombinant vaccinia virus expressing human retrovirus genes and method for producing htlb-iii envelope proteins
|
CA1310924C
(en)
*
|
1986-04-24 |
1992-12-01 |
Francis P. Mccormick |
Infective drug delivery system
|
NZ220645A
(en)
*
|
1986-06-20 |
1989-10-27 |
Merck & Co Inc |
Modified varicella-zoster virus and its cultivation
|
JPH0695935B2
(ja)
*
|
1986-07-31 |
1994-11-30 |
東燃株式会社 |
ワクチニアウイルス株
|
US5744133A
(en)
*
|
1986-08-13 |
1998-04-28 |
Transgene S.A. |
Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventitive or curative treatment of the corresponding tumor
|
US6007806A
(en)
*
|
1986-08-13 |
1999-12-28 |
Transgene S.A. |
Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventive or curative treatment of the corresponding tumor
|
JPH0795956B2
(ja)
*
|
1986-09-22 |
1995-10-18 |
京都大学長 |
ポックスウイルス由来発現制御領域
|
AU614064B2
(en)
*
|
1986-09-22 |
1991-08-22 |
President of Kyoto University, The |
Gene for A-type inclusion body of poxvirus
|
US5242829A
(en)
*
|
1986-09-23 |
1993-09-07 |
Therion Biologics Corporation |
Recombinant pseudorabies virus
|
EP0261940A3
(de)
*
|
1986-09-23 |
1989-07-05 |
Applied Biotechnology, Inc. |
Pseudorabies-Impfstoffe und DNS-Vektoren zur Rekombination mit Poxviren
|
US5348741A
(en)
*
|
1987-02-03 |
1994-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vector for recombinant poxvirus expressing rabies virus glycoprotein
|
WO1988006182A1
(en)
*
|
1987-02-10 |
1988-08-25 |
Toa Nenryo Kogyo Kabushiki Kaisha |
Bovine leukemia virus vaccine prepared by using recombinant vaccinia virus
|
NZ219515A
(en)
*
|
1987-02-10 |
1989-09-27 |
Wellcome Found |
Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope
|
DE3852304T3
(de)
*
|
1987-03-02 |
1999-07-01 |
Enzon Labs Inc., Piscataway, N.J. |
Organismus als Träger für "Single Chain Antibody Domain (SCAD)".
|
EP0347425B1
(de)
|
1987-03-02 |
1995-12-27 |
Whitehead Institute For Biomedical Research |
Rekombinant-mykobakterielle impfstoffe
|
US5578468A
(en)
*
|
1987-08-10 |
1996-11-26 |
Duke University |
Site-specific RNA cleavage
|
US5443964A
(en)
*
|
1987-08-10 |
1995-08-22 |
Duke University |
Poxvirus insertion/expression vector
|
DE10399032I1
(de)
*
|
1987-08-28 |
2004-01-29 |
Health Research Inc |
Rekombinante Viren.
|
DE3890874T1
(de)
*
|
1987-08-28 |
1989-12-21 |
Health Research Inc |
Rekombinante avipoxviren
|
US6699475B1
(en)
|
1987-09-02 |
2004-03-02 |
Therion Biologics Corporation |
Recombinant pox virus for immunization against tumor-associated antigens
|
JPH084508B2
(ja)
*
|
1987-09-16 |
1996-01-24 |
国立予防衛生研究所長 |
組み換えワクチニアウイルス
|
US5286639A
(en)
*
|
1987-09-16 |
1994-02-15 |
Nippon Zeon Co., Ltd. |
Recombinant avipoxvirus
|
FR2632863B2
(fr)
*
|
1987-10-29 |
1990-08-31 |
Transgene Sa |
Virus du fowlpox recombinant et vaccins derives de ces virus
|
JP2704258B2
(ja)
*
|
1987-10-31 |
1998-01-26 |
日本臓器製薬株式会社 |
組み換えワクチニアウイルス
|
CA1341245C
(en)
*
|
1988-01-12 |
2001-06-05 |
F. Hoffmann-La Roche Ag |
Recombinant vaccinia virus mva
|
US5069901A
(en)
*
|
1988-02-03 |
1991-12-03 |
Jones Elaine V |
Preparation of a recombinant subunit vaccine against pseudorabies infection
|
US20030150019A1
(en)
*
|
1988-02-26 |
2003-08-07 |
Large Scale Biology Corporation |
Monopartite RNA virus transformation vectors
|
US5316931A
(en)
*
|
1988-02-26 |
1994-05-31 |
Biosource Genetics Corp. |
Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes
|
US6284492B1
(en)
|
1988-02-26 |
2001-09-04 |
Large Scale Biology Corporation |
Recombinant animal viral nucleic acids
|
US6054566A
(en)
*
|
1988-02-26 |
2000-04-25 |
Biosource Technologies, Inc. |
Recombinant animal viral nucleic acids
|
US5997859A
(en)
*
|
1988-03-21 |
1999-12-07 |
Chiron Corporation |
Method for treating a metastatic carcinoma using a conditionally lethal gene
|
US6569679B1
(en)
|
1988-03-21 |
2003-05-27 |
Chiron Corporation |
Producer cell that generates adenoviral vectors encoding a cytokine and a conditionally lethal gene
|
US5631154A
(en)
*
|
1988-06-10 |
1997-05-20 |
Therion Biologics, Incorporated |
Self assembled, defective, non-self-propagating lentivirus particles
|
US5614404A
(en)
*
|
1988-06-10 |
1997-03-25 |
Theriod Biologics, Incorporated |
Self-assembled, defective, non-self-propagating lentivirus particles
|
US5747324A
(en)
*
|
1988-06-10 |
1998-05-05 |
Therion Biologics Corporation |
Self-assembled, defective, non-self-propagating lentivirus particles
|
US5093258A
(en)
*
|
1988-08-26 |
1992-03-03 |
Therion Biologics Corporation |
Recombinant fowlpox virus and recombination vector
|
US5223409A
(en)
*
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
GB8821441D0
(en)
*
|
1988-09-13 |
1988-10-12 |
Animal Health Inst |
Viral vectors
|
US7118757B1
(en)
|
1988-12-19 |
2006-10-10 |
Wyeth Holdings Corporation |
Meningococcal class 1 outer-membrane protein vaccine
|
DE69032841T2
(de)
*
|
1989-01-23 |
1999-05-12 |
Chiron Corp., Emeryville, Calif. |
Rekombinante zellen für therapien von infektionen und hyperprolieferative störungen und deren herstellung
|
US6248333B1
(en)
|
1990-04-04 |
2001-06-19 |
Health Research Inc. |
Isolated nucleic acid sequence of equine herpesvirus type 1 glycoprotein D (EHV-1 gD)
|
US5691170A
(en)
*
|
1989-04-18 |
1997-11-25 |
Therion Biologics |
Generation of hybrid genes and proteins by virus-mediated recombination
|
US7413537B2
(en)
*
|
1989-09-01 |
2008-08-19 |
Dyax Corp. |
Directed evolution of disulfide-bonded micro-proteins
|
US5221607A
(en)
*
|
1989-09-18 |
1993-06-22 |
Scios Nova Inc. |
Assays and reagents for amyloid deposition
|
WO1991006658A2
(en)
*
|
1989-10-24 |
1991-05-16 |
Cetus Corporation |
Infective protein delivery system
|
JPH06500232A
(ja)
*
|
1990-08-15 |
1994-01-13 |
サリオン・バイオロジクス・コーポレイシヨン |
自己集合性複製欠陥型ハイブリッドウイルス粒子
|
US7374768B1
(en)
|
1990-09-25 |
2008-05-20 |
Xenova Research Limited |
Viral vaccines
|
AU8740491A
(en)
*
|
1990-09-28 |
1992-04-28 |
Protein Engineering Corporation |
Proteinaceous anti-dental plaque agents
|
AU9137391A
(en)
*
|
1990-11-29 |
1992-06-25 |
Diagnostic Hybrids, Inc. |
Method for in situ detection and identification of nucleic acid sequences
|
EP0575485A1
(de)
*
|
1991-03-01 |
1993-12-29 |
Dyax Corp. |
Verfahren zur entwicklung bindender miniproteine
|
US5756101A
(en)
*
|
1991-07-01 |
1998-05-26 |
Pasteur Merieux Serums Et Vaccins |
Malaria recombinant poxvirus
|
US5997878A
(en)
|
1991-03-07 |
1999-12-07 |
Connaught Laboratories |
Recombinant poxvirus-cytomegalovirus, compositions and uses
|
US5759552A
(en)
*
|
1991-03-07 |
1998-06-02 |
Virogenetics Corporation |
Marek's disease virus recombinant poxvirus vaccine
|
US6872550B1
(en)
|
1991-07-11 |
2005-03-29 |
Baxter Vaccine Ag |
Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
|
US6221363B1
(en)
*
|
1991-07-11 |
2001-04-24 |
Baxter Aktiengesellschaft |
Vaccine for the prevention of lyme disease
|
DE69229390T2
(de)
|
1991-08-26 |
1999-11-11 |
Immuno Ag, Wien |
Direkt molekuläre Klonierung eines modifizierten Genoms eines Chordopocken-Virus
|
PT623172E
(pt)
*
|
1992-01-13 |
2005-02-28 |
Virogenetics Corp |
Vacina de virus vaccinia recombinante do virus da doenca de marek
|
WO1995014091A2
(en)
|
1993-11-18 |
1995-05-26 |
Chiron Viagene, Inc. |
Compositions and methods for utilizing conditionally lethal genes
|
DK0758397T3
(da)
*
|
1994-04-29 |
2005-10-10 |
Baxter Healthcare Sa |
Rekombinante poxvira med fremmede polynucleotider i essentielle regioner
|
US5888814A
(en)
*
|
1994-06-06 |
1999-03-30 |
Chiron Corporation |
Recombinant host cells encoding TNF proteins
|
DE69635472T2
(de)
|
1995-07-03 |
2006-04-13 |
Akzo Nobel N.V. |
Impfstoff gegen Geflügelkokzidose
|
US6592877B1
(en)
*
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
US6290969B1
(en)
*
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
US5858373A
(en)
*
|
1995-12-01 |
1999-01-12 |
Virogenetics Corporation |
Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them
|
ATE386811T1
(de)
|
1996-04-05 |
2008-03-15 |
Novartis Vaccines & Diagnostic |
Alphaviren-vektors mit eine reduzierte inhibierung der synthese von zellmakromolekülen
|
US5858378A
(en)
*
|
1996-05-02 |
1999-01-12 |
Galagen, Inc. |
Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen
|
EP2112225A1
(de)
|
1996-07-25 |
2009-10-28 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Rekombinanter Pockenvirus zur Immunisierung gegen mit Tumoren assoziierte Antigene
|
EP2298900A1
(de)
|
1996-09-17 |
2011-03-23 |
Novartis Vaccines and Diagnostics, Inc. |
Zusammensetzungen und Verfahren zur Behandlung intrazellulärer Erkrankungen
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
US6261562B1
(en)
|
1997-02-25 |
2001-07-17 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US5990091A
(en)
|
1997-03-12 |
1999-11-23 |
Virogenetics Corporation |
Vectors having enhanced expression, and methods of making and uses thereof
|
AUPO652897A0
(en)
|
1997-04-30 |
1997-05-29 |
University Of Melbourne, The |
Synthetic peptide constructs for the diagnosis and treatment of periodontitis
|
US7087713B2
(en)
*
|
2000-02-25 |
2006-08-08 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
FR2766091A1
(fr)
|
1997-07-18 |
1999-01-22 |
Transgene Sa |
Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee
|
WO1999006576A1
(en)
|
1997-08-04 |
1999-02-11 |
Calydon, Inc. |
A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
|
US6517843B1
(en)
|
1999-08-31 |
2003-02-11 |
Merial |
Reduction of porcine circovirus-2 viral load with inactivated PCV-2
|
EP2386629A1
(de)
|
1997-10-14 |
2011-11-16 |
Darwin Molecular Corporation |
Thymidinkinasemutanten und Fusionsproteine mit Thymidinkinase- und Guanylatkinaseaktivität
|
CA2308606A1
(en)
|
1997-11-06 |
1999-05-20 |
Chiron S.P.A. |
Neisserial antigens
|
US8129500B2
(en)
|
1997-12-10 |
2012-03-06 |
Csl Limited |
Porphyromonas gingivalis polypeptides and nucleotides
|
GB9726398D0
(en)
|
1997-12-12 |
1998-02-11 |
Isis Innovation |
Polypeptide and coding sequences
|
AU2010699A
(en)
|
1997-12-24 |
1999-07-19 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse
|
DE69941567D1
(de)
|
1998-01-14 |
2009-12-03 |
Novartis Vaccines & Diagnostic |
Antigene aus neisseria meningitidis
|
US6136794A
(en)
*
|
1998-02-02 |
2000-10-24 |
Merck & Co., Inc. |
Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist
|
EP2003201A3
(de)
|
1998-03-18 |
2008-12-31 |
Corixa Corporation |
Verbindungen und Verfahren für Therapie und Diagnose von Lungenkrebs
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
WO1999055345A1
(en)
|
1998-04-30 |
1999-11-04 |
The General Hospital Corporation |
Combination viral-based and gene-based therapy of tumors
|
CN101293920B
(zh)
|
1998-05-01 |
2012-07-18 |
诺华疫苗和诊断公司 |
脑膜炎奈瑟球菌抗原和组合物
|
EP2272859B1
(de)
|
1998-08-07 |
2014-10-22 |
University of Washington |
Immunologische Herpes-Simplex Antigene und Verfahren zu ihrer Verwendung
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
EP1121437B1
(de)
|
1998-10-15 |
2008-02-20 |
Novartis Vaccines and Diagnostics, Inc. |
Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen
|
WO2000034483A2
(en)
|
1998-12-08 |
2000-06-15 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
AU2367600A
(en)
|
1998-12-16 |
2000-07-03 |
Chiron Corporation |
Human cyclin-dependent kinase ((hpnqalre))
|
US20020119158A1
(en)
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US6579973B1
(en)
|
1998-12-28 |
2003-06-17 |
Corixa Corporation |
Compositions for the treatment and diagnosis of breast cancer and methods for their use
|
US6864235B1
(en)
*
|
1999-04-01 |
2005-03-08 |
Eva A. Turley |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US6911429B2
(en)
*
|
1999-04-01 |
2005-06-28 |
Transition Therapeutics Inc. |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
KR20020007354A
(ko)
|
1999-04-02 |
2002-01-26 |
길리스 스티브 |
폐암의 치료 및 진단에 유용한 화합물 및 방법
|
US8143386B2
(en)
*
|
1999-04-07 |
2012-03-27 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
NZ530640A
(en)
|
1999-04-30 |
2006-06-30 |
Chiron S |
Conserved neisserial antigens
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
US6497883B1
(en)
|
1999-06-10 |
2002-12-24 |
Merial |
Porcine circovirus recombinant poxvirus vaccine
|
US7101989B1
(en)
|
1999-07-09 |
2006-09-05 |
University Of North Carolina At Chapel Hill |
DsrA protein and polynucleotides encoding the same
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
US7311922B1
(en)
*
|
1999-10-07 |
2007-12-25 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
ATE391726T1
(de)
|
1999-10-22 |
2008-04-15 |
Sanofi Pasteur Ltd |
Modifiziertes gp100 und dessen verwendung
|
AU784203B2
(en)
|
1999-10-29 |
2006-02-23 |
Glaxosmithkline Biologicals S.A. |
Neisserial antigenic peptides
|
NZ519655A
(en)
*
|
1999-12-21 |
2004-04-30 |
Merial Sas |
Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen
|
AUPQ485999A0
(en)
|
1999-12-24 |
2000-02-03 |
Csl Limited |
P. gingivalis antigenic composition
|
RU2279889C2
(ru)
|
2000-01-17 |
2006-07-20 |
Чирон С.Р.Л. |
ВАКЦИНА ВЕЗИКУЛ НАРУЖНЫХ МЕМБРАН (OMV), СОДЕРЖАЩАЯ БЕЛКИ НАРУЖНОЙ МЕБРАНЫ N.Meningitidis СЕРОЛОГИЧЕСКОЙ ГРУППЫ В
|
PL216780B1
(pl)
|
2000-01-25 |
2014-05-30 |
Univ Queensland Of Santa Lucia |
Wyizolowane białka zawierające konserwatywne obszary antygenu powierzchniowego NhhA z Neisseria meningitidis, białka fuzyjne, kompozycja farmaceutyczna, przeciwciało monoklonalne lub wiążący antygen fragment przeciwciała monoklonalnego, wyizolowany kwas nukleinowy, konstrukt ekspresyjny, komórka gospodarza, sposób wytwarzania rekombinowanego białka, sposób wykrywania N. meningitidis w próbce biologicznej, sposób diagnozowania zakażenia N. meningitidis oraz sposób wykrywania N. meningitidis w próbce biologicznej uzyskanej od pacjenta oraz zastosowanie wyizolowanego białka, białka fuzyjnego i konstruktu ekspresyjnego
|
ES2389445T3
(es)
|
2000-02-23 |
2012-10-26 |
Glaxosmithkline Biologicals Sa |
Compuestos novedosos
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
ATE389020T1
(de)
|
2000-04-21 |
2008-03-15 |
Corixa Corp |
Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
|
EP1278541A1
(de)
*
|
2000-04-28 |
2003-01-29 |
The Government of The United States of America, as represented by The Department of Health and Human Services |
Verbesserung der immunogenität bei der verwendung einer kombination von dns und vacciniavirus-vektor impfstoffen
|
WO2001085932A2
(en)
|
2000-05-10 |
2001-11-15 |
Aventis Pasteur Limited |
Immunogenic polypeptides encoded by mage minigenes and uses thereof
|
DK1284740T3
(da)
|
2000-05-19 |
2008-08-04 |
Corixa Corp |
Profylaktisk og terapeutisk behandling af infektiöse sygdomme, autoimmunsygdomme og allergiske sygdomme med monosaccharidbaserede forbindelser
|
EP1950297A2
(de)
|
2000-05-31 |
2008-07-30 |
Novartis Vaccines and Diagnostics, Inc. |
Zusammensetzungen und Verfahren zur Behandlung neoplastischer Erkrankungen mithilfe von Chemotherapie und Strahlungssensibilisatoren
|
SI1542732T1
(sl)
|
2000-06-20 |
2010-01-29 |
Corixa Corp Csc The United Sta |
Fuzijski proteini Mycobacterium tuberculosis
|
AU2001273149A1
(en)
|
2000-06-28 |
2002-01-08 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
AU8467201A
(en)
*
|
2000-07-27 |
2002-02-13 |
Univ Pennsylvania |
Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses
|
US7691821B2
(en)
|
2001-09-19 |
2010-04-06 |
University Of South Florida |
Inhibition of SHIP to enhance stem cell harvest and transplantation
|
US20020165192A1
(en)
*
|
2000-09-19 |
2002-11-07 |
Kerr William G. |
Control of NK cell function and survival by modulation of ship activity
|
US7939087B2
(en)
|
2000-10-27 |
2011-05-10 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from Streptococcus groups A & B
|
US20050196755A1
(en)
*
|
2000-11-17 |
2005-09-08 |
Maurice Zauderer |
In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
|
ATE352040T1
(de)
*
|
2000-11-17 |
2007-02-15 |
Univ Rochester |
In-vitro verfahren zur herstellung und identifizierung von immunglobulin moleküle in eukaryotischen zellen
|
AU2002338446A1
(en)
*
|
2001-01-23 |
2002-11-05 |
University Of Rochester Medical Center |
Methods of producing or identifying intrabodies in eukaryotic cells
|
US20020108132A1
(en)
*
|
2001-02-02 |
2002-08-08 |
Avigenics Inc. |
Production of a monoclonal antibody by a transgenic chicken
|
AU2002255495A1
(en)
*
|
2001-02-02 |
2002-08-19 |
University Of Rochester |
Methods of identifying regulator molecules
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
US7541512B2
(en)
*
|
2001-03-30 |
2009-06-02 |
Synageva Biopharma Corp. |
Avians containing a lysozyme promoter transgene
|
EP1478751A4
(de)
|
2001-03-30 |
2005-10-19 |
Avigenics Inc |
Lysozym-promotor in vögeln
|
US7176300B2
(en)
*
|
2001-03-30 |
2007-02-13 |
Avigenics, Inc. |
Avian lysozyme promoter
|
FR2823222B1
(fr)
|
2001-04-06 |
2004-02-06 |
Merial Sas |
Vaccin contre le virus de la fievre du nil
|
GB0109515D0
(en)
*
|
2001-04-17 |
2001-06-06 |
Neg Micon As |
A method for transporting a set of large longitudinal items, a package system to be used by the method and use of such a package system
|
CA2446788A1
(en)
|
2001-05-09 |
2002-11-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US20030148973A1
(en)
*
|
2001-05-23 |
2003-08-07 |
Peter Emtage |
MAGE-A1 peptides for treating or preventing cancer
|
EP1281767A3
(de)
*
|
2001-07-31 |
2003-05-28 |
Aladar A. Szalay |
Lichtausstrahlende Mikroorganismen und Zellen für die Diagnose und Therapie von Tumoren
|
US20030113919A1
(en)
*
|
2001-08-17 |
2003-06-19 |
Aventis Pasteur, Ltd. |
Immunogenic targets for melanoma
|
US7550650B2
(en)
*
|
2001-09-18 |
2009-06-23 |
Synageva Biopharma Corp. |
Production of a transgenic avian by cytoplasmic injection
|
ES2344253T3
(es)
|
2001-10-11 |
2010-08-23 |
MERCK SHARP & DOHME CORP. |
Vacuna contra el virus de la hepatitis c.
|
WO2003085087A2
(en)
|
2002-04-09 |
2003-10-16 |
Aventis Pasteur, Limited |
Modified cea nucleic acid and expression vectors
|
US20030214690A1
(en)
*
|
2001-11-26 |
2003-11-20 |
Escuti Michael J. |
Holographic polymer photonic crystal
|
US7294507B2
(en)
*
|
2001-11-30 |
2007-11-13 |
Avigenics, Inc. |
Ovomucoid promoters and methods of use
|
US20100333219A1
(en)
*
|
2001-11-30 |
2010-12-30 |
Synageva Biopharma Corp. |
Methods of protein production using ovomucoid regulatory regions
|
US6875588B2
(en)
|
2001-11-30 |
2005-04-05 |
Avigenics, Inc. |
Ovomucoid promoter and methods of use
|
US7335761B2
(en)
*
|
2001-11-30 |
2008-02-26 |
Avigenics, Inc. |
Avian gene expression controlling regions
|
JP4413617B2
(ja)
|
2001-12-12 |
2010-02-10 |
カイロン ソチエタ ア レスポンサビリタ リミタータ |
Chlamydiatrachomatisに対する免疫化
|
EP2224012B1
(de)
|
2001-12-17 |
2013-01-30 |
Corixa Corporation |
Zusammensetzungen und Verfahren zur Therapie und Diagnose von entzündlicher Darmerkrankung
|
US7026465B2
(en)
*
|
2002-02-15 |
2006-04-11 |
Corixa Corporation |
Fusion proteins of Mycobacterium tuberculosis
|
US7135562B2
(en)
|
2002-03-14 |
2006-11-14 |
University Of Cincinnati |
Avian iFABP gene expression controlling region
|
WO2003078640A2
(en)
|
2002-03-15 |
2003-09-25 |
Baxter International Inc. |
Recombinant drug-sensitive vaccinia virus as smallpox vaccine
|
US20040241723A1
(en)
*
|
2002-03-18 |
2004-12-02 |
Marquess Foley Leigh Shaw |
Systems and methods for improving protein and milk production of dairy herds
|
WO2004041997A2
(en)
*
|
2002-05-01 |
2004-05-21 |
National Institutes Of Health |
Immunotherapy regimens in hiv-infected patients
|
US20030206916A1
(en)
*
|
2002-05-03 |
2003-11-06 |
Rush-Presbyterian-St. Luke's Medical Center |
Immunogenic peptides
|
CA2492598C
(en)
|
2002-07-18 |
2013-12-17 |
University Of Washington |
Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same
|
DE60336653D1
(de)
|
2002-08-07 |
2011-05-19 |
Bavarian Nordic As |
Vaccinia virus wirtspektrum gene zur erhöhung des titers von avipoxviren
|
EP1545575A4
(de)
|
2002-09-19 |
2006-04-05 |
Us Gov Health & Human Serv |
P. ariasi polypeptide, p. perniciosus polypeptide und anwendungsverfahren
|
US20070224124A1
(en)
*
|
2002-09-30 |
2007-09-27 |
University Of South Florida |
Novel SH2containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein
|
EP1633786A4
(de)
*
|
2002-10-09 |
2007-07-25 |
Rinat Neuroscience Corp |
Verfahren zur behandlung der alzheimer-krankheit mit antikörpern gegen amyloid-beta-peptid und zusammensetzungen daraus
|
EP1556082A1
(de)
*
|
2002-10-22 |
2005-07-27 |
Aventis Pasteur Limited |
Impfstoffe gegen krebs mit hochdosierten zytokinen als adjuvans
|
MXPA05004714A
(es)
|
2002-10-29 |
2006-03-17 |
Us Gov Health & Human Serv |
Polipeptidos de lutzomyia longipalpis y metodos de uso.
|
AU2003288660A1
(en)
|
2002-11-15 |
2004-06-15 |
Chiron Srl |
Unexpected surface proteins in neisseria meningitidis
|
US7960522B2
(en)
|
2003-01-06 |
2011-06-14 |
Corixa Corporation |
Certain aminoalkyl glucosaminide phosphate compounds and their use
|
RU2389732C2
(ru)
|
2003-01-06 |
2010-05-20 |
Корикса Корпорейшн |
Некоторые аминоалкилглюкозаминидфосфатные производные и их применение
|
US8067535B2
(en)
*
|
2003-01-24 |
2011-11-29 |
The University Of Massachusetts |
Identification of gene sequences and proteins involved in vaccinia virus dominant T cell epitopes
|
CN1980571A
(zh)
*
|
2003-01-24 |
2007-06-13 |
阿维季尼克斯股份有限公司 |
禽类及禽蛋中表达的外源蛋白质
|
EP1624890B1
(de)
*
|
2003-01-24 |
2011-07-13 |
University Of Massachusetts Medical Center |
Identifikation von vaccinia-virus-dominanten t-zell-epitopen
|
EP1606419A1
(de)
|
2003-03-18 |
2005-12-21 |
Quantum Genetics Ireland Limited |
Systeme und methoden zur erhohung der milchproduktion in tieren
|
WO2004087201A2
(en)
|
2003-03-28 |
2004-10-14 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mva virus expressing modified hiv envelope, gag, and pol genes
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
WO2004092216A1
(en)
*
|
2003-04-15 |
2004-10-28 |
Trangene S.A. |
Carcinoembryonic antigen (cea) lacking a signal peptide, nucleic acid encoding it and fusion of cea with a t cell epitope and their use for the treatment and/or prophylaxis of cancer
|
WO2004098634A2
(en)
*
|
2003-04-30 |
2004-11-18 |
Government Of The United States Of America As Represented By The Sercretary Of The Department Of Health And Human Services National Institutes Of Health |
Protein arginine n-methyltransferase 2 (prmt-2)
|
US7468273B2
(en)
|
2003-05-01 |
2008-12-23 |
Meial Limited |
Canine GHRH gene, polypeptides and methods of use
|
US8207314B2
(en)
*
|
2003-05-16 |
2012-06-26 |
Sanofi Pasteur Limited |
Tumor antigens for prevention and/or treatment of cancer
|
DE602004018927D1
(de)
*
|
2003-06-18 |
2009-02-26 |
Genelux Corp |
Modifizierte rekombinante vacciniaviren, verwendungen davon
|
WO2005007673A2
(en)
*
|
2003-07-03 |
2005-01-27 |
Rush University Medical Center |
Immunogenic peptides
|
ES2359473T3
(es)
|
2003-07-21 |
2011-05-23 |
Transgene S.A. |
Citoquinas multifuncionales.
|
JP4672659B2
(ja)
|
2003-07-21 |
2011-04-20 |
トランジェーヌ、ソシエテ、アノニム |
改善されたシトシンデアミナーゼ活性を有するポリペプチド
|
JP4668919B2
(ja)
*
|
2003-10-08 |
2011-04-13 |
サノフィ パストゥール インコーポレイテッド |
修飾cea/b7ベクター
|
ES2417019T3
(es)
|
2003-11-13 |
2013-08-05 |
University Of Georgia Research Foundation, Inc. |
Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa
|
US7763592B1
(en)
|
2003-11-20 |
2010-07-27 |
University Of South Florida |
SHIP-deficiency to increase megakaryocyte progenitor production
|
US7807646B1
(en)
|
2003-11-20 |
2010-10-05 |
University Of South Florida |
SHIP-deficiency to increase megakaryocyte progenitor production
|
ATE510928T1
(de)
|
2004-02-19 |
2011-06-15 |
Univ Alberta |
Leptinpromotor-polymorphismen und verwendungen davon
|
US8268324B2
(en)
|
2004-03-29 |
2012-09-18 |
Galpharma Co., Ltd. |
Modified galectin 9 proteins and use thereof
|
WO2006019906A1
(en)
|
2004-07-14 |
2006-02-23 |
The Regents Of The University Of California |
Biomarker for early detection of ovarian cancer
|
US7807165B2
(en)
*
|
2004-07-30 |
2010-10-05 |
Rinat Neuroscience Corp. |
Antibodies directed against amyloid-beta peptide and methods using same
|
CA2579764A1
(en)
|
2004-08-10 |
2006-02-23 |
Institute For Multiple Myeloma And Bone Cancer Research |
Methods of regulating differentiation and treating of multiple myeloma
|
WO2006026667A2
(en)
|
2004-08-27 |
2006-03-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant mva viruses expressing glade a/g, clade b, and clade c modified hiv, gag and pol genes
|
KR101505496B1
(ko)
|
2004-09-22 |
2015-03-25 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
스태필로코쿠스에 대한 예방접종에 사용하기 위한 면역원성 조성물
|
WO2006032104A1
(en)
|
2004-09-23 |
2006-03-30 |
The University Of Melbourne |
Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection
|
EP3312272B1
(de)
|
2004-10-08 |
2019-08-28 |
The Government of The United States of America as represented by The Secretary of The Department of Health and Human Services |
Modulation der replikationsrate durch verwendung von seltener verwendeten synonymen kodonen
|
US20060194740A1
(en)
*
|
2005-02-25 |
2006-08-31 |
Ulevitch Richard J |
NOD1 as an anti-tumor agent
|
EP1701165A1
(de)
|
2005-03-07 |
2006-09-13 |
Johannes Dr. Coy |
Therapeutischer und diagnostischer Gebrauch von TKTL1 sowie seiner Inhibitoren und Aktivatoren
|
UA97943C2
(ru)
|
2005-03-31 |
2012-04-10 |
ГлаксоСмитКлайн Байолоджикалз с.а. |
Вакцина против инфекции chlamydia
|
WO2006113927A2
(en)
*
|
2005-04-20 |
2006-10-26 |
University Of Washington |
Immunogenic vaccinia peptides and methods of using same
|
DK1881845T3
(da)
|
2005-04-25 |
2010-06-07 |
Merial Ltd |
Nipah-virusvacciner
|
DK2457926T3
(da)
|
2005-04-29 |
2015-01-05 |
Glaxosmithkline Biolog Sa |
Ny fremgangsmåde til forebyggelse eller behandling af M. tuberkulose-infektion
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
CA2610919C
(en)
|
2005-06-17 |
2013-09-10 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Hepatitis c virus nucleic acid vaccine
|
EP1907425B1
(de)
*
|
2005-07-22 |
2014-01-08 |
Y's Therapeutics Co., Ltd. |
Anti-cd26-antikörper und verfahren zu ihrer verwendung
|
WO2007016597A2
(en)
*
|
2005-07-29 |
2007-02-08 |
The Regents Of The University Of California |
Targeting tnf-alpha converting enzyme (tace)-dependent growth factor shedding in cancer therapy
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
EP2357000A1
(de)
|
2005-10-18 |
2011-08-17 |
Novartis Vaccines and Diagnostics, Inc. |
Mukosale und systemische Immunisierungen mit Alphavirus-Replikonpartikeln
|
CA2629522A1
(en)
|
2005-11-14 |
2007-05-18 |
Merial Limited |
Gene therapy for renal failure
|
US7771995B2
(en)
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
US7745158B2
(en)
*
|
2005-12-14 |
2010-06-29 |
Kimberly-Clark Worldwide, Inc. |
Detection of secreted aspartyl proteases from Candida species
|
AU2007239095B2
(en)
|
2006-01-09 |
2012-05-03 |
The Regents Of The University Of California |
Immunostimulatory combinations for vaccine adjuvants
|
WO2007082105A2
(en)
|
2006-01-16 |
2007-07-19 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chlamydia vaccine
|
BRPI0708865A8
(pt)
|
2006-03-14 |
2019-01-22 |
Univ Oregon Health & Science |
métodos para produzir uma resposta imune à tuberculose
|
JP2009531464A
(ja)
|
2006-03-29 |
2009-09-03 |
メリアル リミテッド |
連鎖球菌に対するワクチン
|
CA2648718A1
(en)
|
2006-04-07 |
2007-10-18 |
The Research Foundation Of State University Of New York |
Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
|
US20090060947A1
(en)
*
|
2006-05-19 |
2009-03-05 |
Sanofi Pasteur, Inc. |
Immunological compositions
|
US7862821B2
(en)
|
2006-06-01 |
2011-01-04 |
Merial Limited |
Recombinant vaccine against bluetongue virus
|
US20100015168A1
(en)
|
2006-06-09 |
2010-01-21 |
Novartis Ag |
Immunogenic compositions for streptococcus agalactiae
|
JP2009544279A
(ja)
*
|
2006-06-27 |
2009-12-17 |
オーラル ヘルス オーストラリア ピーティーワイ リミテッド |
歯周病の予防に有用なポルフィロモナス・ジンジバリスポリペプチド
|
EP2415783B1
(de)
*
|
2006-10-16 |
2016-12-14 |
Genelux Corporation |
Modifizierte Impfstoffvirusstämme zur Verwendung in einem Diagnose- und Therapieverfahren
|
US8202967B2
(en)
|
2006-10-27 |
2012-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
|
WO2008091311A1
(en)
*
|
2007-01-26 |
2008-07-31 |
Synageva Biopharma Corp |
Transgene expression in avians
|
RU2482189C2
(ru)
|
2007-01-30 |
2013-05-20 |
Трансген С.А. |
Полипептиды е2 папилломавируса, применяемые для вакцинации
|
EP2125868B1
(de)
|
2007-02-28 |
2015-06-10 |
The Govt. Of U.S.A. As Represented By The Secretary Of The Department Of Health And Human Services |
Brachyurie-polypeptide und verwendungsverfahren
|
US20080234194A1
(en)
*
|
2007-03-20 |
2008-09-25 |
Harold Brem |
Growth factor mediated cosmeceuticals and use thereof to enhance skin quality
|
US8673859B2
(en)
*
|
2007-03-20 |
2014-03-18 |
New York University |
GM-CSF cosmeceutical compositions and methods of use thereof
|
US20090081639A1
(en)
*
|
2007-05-31 |
2009-03-26 |
Phil Hill |
Assay for sensitivity to chemotherapeutic agents
|
EP2171071B1
(de)
*
|
2007-06-15 |
2015-08-05 |
Genelux Corporation |
Für ein natriumabhängiges transporterprotein codierende vacciniavirus-vektoren zur bildlichen darstellung und/oder behandlung von tumoren
|
EP3061462B1
(de)
|
2007-07-02 |
2019-02-27 |
Etubics Corporation |
Verfahren und zusammensetzungen zur erzeugung eines adenovirusvektors zur verwendung mit mehreren impfungen
|
US20100297179A1
(en)
|
2007-07-12 |
2010-11-25 |
Stuart Geoffrey Dashper |
Immunology Treatment for Biofilms
|
US8241611B2
(en)
|
2007-07-12 |
2012-08-14 |
Oral Health Austrailia Pty. Ltd. |
Biofilm treatment
|
US8470977B2
(en)
|
2008-03-14 |
2013-06-25 |
Transgene S.A. |
Antibody against the CSF-1R
|
US10000568B2
(en)
|
2008-04-10 |
2018-06-19 |
Cell Signaling Technology, Inc. |
Compositions and methods for detecting EGFR in cancer
|
EP2899203B1
(de)
|
2008-05-08 |
2019-07-10 |
Boehringer Ingelheim Animal Health USA Inc. |
Leishmania impfstoff unter verwendung von sandmücken speichelimmunogen
|
KR101721904B1
(ko)
|
2008-08-29 |
2017-04-11 |
오럴 헬스 오스트레일리아 피티와이 엘티디 |
P.진지발리스 감염의 예방, 치료 및 진단
|
HUE037270T2
(hu)
|
2008-10-10 |
2018-08-28 |
Childrens Medical Center |
Biokémiailag stabilizált HIV-1 ENV trimer vakcina
|
US8691502B2
(en)
|
2008-10-31 |
2014-04-08 |
Tremrx, Inc. |
T-cell vaccination with viral vectors via mechanical epidermal disruption
|
ES2699685T3
(es)
|
2008-11-18 |
2019-02-12 |
Beth Israel Deaconess Medical Ct Inc |
Vacunas antivíricas con inmunogenicidad celular mejorada
|
US20110287089A1
(en)
|
2009-01-13 |
2011-11-24 |
Karola Rittner |
Use of a saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation
|
EP2382474B1
(de)
|
2009-01-20 |
2015-03-04 |
Transgene SA |
Lösliches icam-1 als biomarker zur vorhersage einer therapeutischen antwort
|
US20100192236A1
(en)
*
|
2009-01-28 |
2010-07-29 |
University Of South Carolina |
Modulation of Delta Opioid Receptor Expression
|
WO2010099472A2
(en)
|
2009-02-27 |
2010-09-02 |
The U.S.A. Of America, As Represented By The Secretary, Department Of Health And Human Services |
Spanx-b polypeptides and their use
|
SG2014014021A
(en)
|
2009-03-24 |
2014-07-30 |
Transgene Sa |
Biomarker for monitoring patients
|
JP2012521786A
(ja)
|
2009-03-30 |
2012-09-20 |
モウント シナイ スクール オフ メディシネ |
インフルエンザウイルスワクチン及びその使用
|
CN102428099B
(zh)
|
2009-04-03 |
2016-03-16 |
梅里亚有限公司 |
运载新城疫病毒的禽疫苗
|
NZ594896A
(en)
|
2009-04-17 |
2013-07-26 |
Transgene Sa |
Biomarker for monitoring patients
|
US20100284977A1
(en)
*
|
2009-04-28 |
2010-11-11 |
University Of South Carolina |
Expression of Anti-Nociceptive Compounds from Endogenously Regulated Promoters
|
WO2010127115A1
(en)
|
2009-04-30 |
2010-11-04 |
Centre Hospitalier Universitaire Vaudois Lausanne (Chuv) |
Modified immunization vectors
|
CA2767458A1
(en)
|
2009-07-10 |
2011-01-13 |
Bruce Acres |
Biomarker for selecting patients and related methods
|
RU2016112465A
(ru)
|
2009-08-21 |
2018-11-27 |
Юниверсити Оф Джорджия Рисерч Фаундейшн, Инк. |
Рекомбинантная вакцина на основе парамиксовирусов птиц и способ её приготовления и применения
|
US8140041B2
(en)
*
|
2009-08-27 |
2012-03-20 |
Mediatek Inc. |
Tunable capacitive device with linearization technique employed therein
|
TWI627281B
(zh)
|
2009-09-02 |
2018-06-21 |
百靈佳殷格翰家畜藥品公司 |
降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物
|
US8961989B2
(en)
|
2009-11-20 |
2015-02-24 |
Oregon Health & Science University |
Methods for producing an immune response to tuberculosis
|
MX2012008790A
(es)
|
2010-01-27 |
2012-08-17 |
Glaxosmithkline Biolog Sa |
Antigenos de tuberculosis modificados.
|
MY162557A
(en)
|
2010-02-26 |
2017-06-15 |
Oral Health Australia Pty Ltd |
Treatment or prevention of infection
|
AU2011224188B2
(en)
|
2010-03-12 |
2015-01-22 |
Boehringer Ingelheim Animal Health USA Inc. |
Bluetongue virus recombinant vaccines and uses thereof
|
CN102939103A
(zh)
|
2010-03-30 |
2013-02-20 |
西奈山医学院 |
流感病毒疫苗及其应用
|
WO2012030720A1
(en)
|
2010-08-31 |
2012-03-08 |
Merial Limited |
Newcastle disease virus vectored herpesvirus vaccines
|
AR083533A1
(es)
|
2010-10-22 |
2013-03-06 |
Boehringer Ingelheim Vetmed |
Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
|
WO2012090073A2
(en)
|
2010-12-30 |
2012-07-05 |
The Netherlands Cancer Institute |
Methods and compositions for predicting chemotherapy sensitivity
|
EP3205353B1
(de)
|
2011-03-21 |
2021-01-13 |
Altimmune Inc. |
Schnell und lange wirkendes immunologisches therapeutikum
|
EP2694678A2
(de)
|
2011-04-04 |
2014-02-12 |
Netherland Cancer Institute |
Verfahren und zusammensetzungen zur vorhersage der resistenz gegenüber einer antikrebsbehandlung
|
US20140296248A1
(en)
|
2011-04-04 |
2014-10-02 |
Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis |
Methods and compositions for predicting resistance to anticancer treatment
|
ES2733211T3
(es)
|
2011-04-15 |
2019-11-28 |
Genelux Corp |
Cepas clonales de virus vaccinia atenuados y métodos de uso de las mismas
|
WO2012145577A1
(en)
|
2011-04-20 |
2012-10-26 |
Merial Limited |
Adjuvanted rabies vaccine with improved viscosity profile
|
EP2701736A1
(de)
|
2011-04-25 |
2014-03-05 |
Advanced Bioscience Laboratories, Inc. |
Trunkierte hiv-hüllproteine (env), verfahren und zugehörige zusammensetzungen
|
WO2012151272A2
(en)
|
2011-05-02 |
2012-11-08 |
Tremrx, Inc. |
T-cell vaccination with viral vectors via mechanical epidermal disruption
|
US10221218B2
(en)
|
2011-05-10 |
2019-03-05 |
The Regents Of The University Of California |
Adenovirus isolated from titi monkeys
|
WO2012154994A2
(en)
|
2011-05-10 |
2012-11-15 |
The Regents Of The University Of Californa |
A novel adenovirus isolated from titi monkeys
|
WO2012166493A1
(en)
|
2011-06-01 |
2012-12-06 |
Merial Limited |
Needle-free administration of prrsv vaccines
|
CN103608030A
(zh)
|
2011-06-21 |
2014-02-26 |
昂科发克特公司 |
用于治疗和诊断癌症的组合物和方法
|
IN2014CN00547A
(de)
|
2011-07-20 |
2015-04-03 |
Merial Ltd |
|
HUE035774T2
(en)
|
2011-08-12 |
2018-05-28 |
Merial Inc |
Biological substances, in particular vaccines, preserved by vacuum
|
AR088028A1
(es)
|
2011-08-15 |
2014-05-07 |
Boehringer Ingelheim Vetmed |
Proteinas h5, de h5n1 para un uso medicinal
|
JP6078067B2
(ja)
|
2011-08-29 |
2017-02-08 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
炎症誘発性状態の治療および予防のためのhdl関連分子の使用
|
WO2013033092A2
(en)
|
2011-09-03 |
2013-03-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Streptococcus suis pilus antigens
|
CA2849434A1
(en)
|
2011-09-20 |
2013-03-28 |
Mount Sinai School Of Medicine |
Influenza virus vaccines and uses thereof
|
HRP20190525T8
(hr)
|
2011-11-30 |
2023-01-20 |
Boehringer Ingelheim Animal Health USA Inc. |
Rekombinantni vektori gallid herpesvirusa 3 (mdv serotip 2) koji eksprimiraju antigene ptičjih patogena i njihove uporabe
|
WO2013083753A2
(en)
|
2011-12-07 |
2013-06-13 |
Institut Pasteur |
Identification of a swine parecho-like virus and applications
|
WO2013083254A1
(en)
|
2011-12-09 |
2013-06-13 |
Bavarian Nordic A/S |
Poxvirus vector for the expression of bacterial antigens linked to tetanus toxin fragment c
|
WO2013093629A2
(en)
|
2011-12-20 |
2013-06-27 |
Netherlands Cancer Institute |
Modular vaccines, methods and compositions related thereto
|
US20140087362A1
(en)
|
2012-03-16 |
2014-03-27 |
Aladar A. Szalay |
Methods for assessing effectiveness and monitoring oncolytic virus treatment
|
WO2013138776A1
(en)
|
2012-03-16 |
2013-09-19 |
Merial Limited |
Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
|
ES2711878T3
(es)
|
2012-03-20 |
2019-05-08 |
Merial Inc |
Vacuna contra el virus del herpes equino 1 recombinante que contiene glicoproteína C mutada y usos de la misma
|
US20130280170A1
(en)
|
2012-04-20 |
2013-10-24 |
Aladar A. Szalay |
Imaging methods for oncolytic virus therapy
|
PE20142406A1
(es)
|
2012-05-04 |
2015-01-23 |
Pfizer |
Antigenos asociados a prostata y regimenes de inmunoterapia basados en vacuna
|
WO2014009433A1
(en)
|
2012-07-10 |
2014-01-16 |
Transgene Sa |
Mycobacterium resuscitation promoting factor for use as adjuvant
|
TWI638829B
(zh)
|
2012-07-10 |
2018-10-21 |
法商傳斯堅公司 |
分枝桿菌抗原疫苗
|
WO2014031178A1
(en)
|
2012-08-24 |
2014-02-27 |
Etubics Corporation |
Replication defective adenovirus vector in vaccination
|
WO2014043535A1
(en)
|
2012-09-14 |
2014-03-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions for the treatment of cancer
|
WO2014043518A1
(en)
|
2012-09-14 |
2014-03-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Brachyury protein, non-poxvirus non-yeast vectors encoding brachyury protein, and their use
|
US20140140959A1
(en)
|
2012-10-05 |
2014-05-22 |
Aladar A. Szalay |
Energy Absorbing-Based Diagnostic and Therapeutic Methods Employing Nucleic Acid Molecules Encoding Chromophore-Producing Enzymes
|
CN109134640A
(zh)
|
2012-10-23 |
2019-01-04 |
爱默蕾大学 |
Gm-csf和il-4轭合物、组合物以及与其相关的方法
|
US9968670B2
(en)
|
2012-12-18 |
2018-05-15 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccines and uses thereof
|
AU2014203886B2
(en)
|
2013-01-07 |
2017-11-02 |
Beth Israel Deaconess Medical Center, Inc. |
Stabilized human immunodeficiency virus (HIV) envelope (Env) trimer vaccines and methods of using the same
|
MX360137B
(es)
|
2013-02-21 |
2018-10-24 |
Boehringer Ingelheim Vetmedica Gmbh |
Proteínas h5 del virus de la influenza h5n1 para usarse como un medicamento.
|
WO2014164697A1
(en)
|
2013-03-12 |
2014-10-09 |
Merial Limited |
Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof
|
US9908930B2
(en)
|
2013-03-14 |
2018-03-06 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
WO2014144844A1
(en)
|
2013-03-15 |
2014-09-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
tRNA DERIVED SMALL RNAs (tsRNAs) INVOLVED IN CELL VIABILITY
|
US20140296139A1
(en)
|
2013-03-15 |
2014-10-02 |
The Regents Of The University Of California |
Mitochondrial-derived peptide mots3 regulates metabolism and cell survival
|
EP2986717A1
(de)
|
2013-04-19 |
2016-02-24 |
The Regents of The University of California |
Lone-star-virus
|
WO2014210546A1
(en)
|
2013-06-27 |
2014-12-31 |
University Of Washington Through Its Center For Commercialization |
Biocompatible polymeric system for targeted treatment of thrombotic and hemostatic disorders
|
EP3695841A3
(de)
|
2013-07-01 |
2020-11-04 |
The Research Foundation for the State University of New York |
Ship-hemmung gegen fettleibigkeit
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
US10716845B2
(en)
|
2013-10-04 |
2020-07-21 |
Beth Israel Deaconess Medical Center, Inc. |
Stabilized human immunodeficiency virus (HIV) clade C envelope (Env) trimer vaccines and methods of using same
|
MX2016004579A
(es)
|
2013-10-10 |
2016-12-09 |
Beth Israel Deaconess Medical Ct Inc |
Proteinas de union del miembro 1 de la familia de transmembrana 4 l-seis (tm4sf1) y metodos de uso de las mismas.
|
WO2015077717A1
(en)
|
2013-11-25 |
2015-05-28 |
The Broad Institute Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
|
WO2015085147A1
(en)
|
2013-12-05 |
2015-06-11 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
AU2014368898B2
(en)
|
2013-12-20 |
2020-06-11 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy with neoantigen vaccine
|
US10238700B2
(en)
|
2014-01-02 |
2019-03-26 |
Genelux Corporation |
Oncolytic virus adjunct therapy with agents that increase virus infectivity
|
US10765731B2
(en)
|
2014-01-09 |
2020-09-08 |
Transgene Sa |
Fusion of heterooligomeric mycobacterial antigens
|
EA201691993A1
(ru)
|
2014-04-03 |
2017-02-28 |
Бёрингер Ингельхайм Ветмедика, Инк. |
Вакцина к вирусу эпидемической диареи свиней
|
EP3157530A4
(de)
|
2014-06-17 |
2018-01-17 |
The Research Foundation for The State University of New York |
Ship-hemmung zur induzierung der expression des granulozytenkoloniestimulierenden faktors bei einer person
|
BR112016030008A2
(pt)
|
2014-06-27 |
2017-10-24 |
Abbott Lab |
método para a detecção de infecção por pegivirus humano 2 em um indivíduo, para a detecção de ácido nucleico de pegivirus humano 2 e para a detecção de pegivirus humano 2 em uma amostra, e, composição
|
EA037583B1
(ru)
|
2014-09-26 |
2021-04-16 |
Бет Изрейэл Диконисс Медикал Сентер, Инк. |
Способы и композиции для индукции защитного иммунитета против инфекции вирусом иммунодефицита человека
|
MX2017005687A
(es)
|
2014-11-03 |
2017-08-21 |
Merial Inc |
Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia.
|
WO2016100977A1
(en)
|
2014-12-19 |
2016-06-23 |
The Broad Institute Inc. |
Methods for profiling the t-cel- receptor repertoire
|
US10975442B2
(en)
|
2014-12-19 |
2021-04-13 |
Massachusetts Institute Of Technology |
Molecular biomarkers for cancer immunotherapy
|
EP3247389A4
(de)
|
2015-01-23 |
2019-10-30 |
Icahn School of Medicine at Mount Sinai |
Influenzavirusschutzimpfpläne
|
WO2016131945A1
(en)
|
2015-02-20 |
2016-08-25 |
Transgene Sa |
Combination product with autophagy modulator
|
US20180071380A1
(en)
|
2015-03-20 |
2018-03-15 |
The Regents Of The University Of Michigan |
Immunogenic compositions for use in vaccination against bordetella
|
RU2733754C2
(ru)
|
2015-05-20 |
2020-10-06 |
Те Брод Инститьют Инк. |
Общие неоантигены
|
TWI750122B
(zh)
|
2015-06-09 |
2021-12-21 |
美商博德研究所有限公司 |
用於贅瘤疫苗之調配物及其製備方法
|
CA2990643C
(en)
|
2015-06-23 |
2023-10-17 |
Merial, Inc. |
Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof
|
EP3225685B1
(de)
*
|
2015-06-30 |
2018-12-12 |
Sysmex Corporation |
Konservierungslösung für zellen, verwendung davon und verfahren zur herstellung von konservierungslösung für zellen
|
CN108135993B
(zh)
|
2015-08-31 |
2022-03-22 |
贝林格尔·英格海姆维特梅迪卡有限公司 |
用于先天性震颤的瘟病毒疫苗
|
CA2996613A1
(en)
|
2015-09-16 |
2017-03-23 |
Boehringer Ingelheim Vetmedica, Inc. |
Salmonella choleraesuis-salmonella typhimurium vaccines
|
US10548970B2
(en)
|
2015-10-05 |
2020-02-04 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human rotavirus G9P[6] strain and use as a vaccine
|
US10780158B2
(en)
|
2015-11-16 |
2020-09-22 |
Georgia State University Research Foundation, Inc. |
Tunable vaccine platform against pathogens of the paramyxovirus family
|
PT3390430T
(pt)
|
2015-12-15 |
2019-11-20 |
Janssen Vaccines & Prevention Bv |
Antígenos, vetores, composições para o vírus da imunodeficiência humana e métodos da sua utilização
|
AU2017206102C1
(en)
|
2016-01-08 |
2022-02-10 |
Geovax Inc. |
Compositions and methods for generating an immune response to a tumor associated antigen
|
RU2718663C2
(ru)
|
2016-01-19 |
2020-04-13 |
Пфайзер Инк. |
Противораковые вакцины
|
WO2017136419A1
(en)
|
2016-02-03 |
2017-08-10 |
Geovax Inc. |
Compositions and methods for generating an immune response to a flavivirus
|
US20190346442A1
(en)
|
2016-04-18 |
2019-11-14 |
The Broad Institute, Inc. |
Improved hla epitope prediction
|
CA3023022A1
(en)
|
2016-05-04 |
2017-11-09 |
Transgene Sa |
Combination therapy with cpg tlr9 ligand
|
CN109641044A
(zh)
|
2016-05-30 |
2019-04-16 |
吉奥瓦科斯公司 |
用于产生对乙型肝炎病毒的免疫应答的组合物和方法
|
CN109641041A
(zh)
|
2016-06-15 |
2019-04-16 |
西奈山伊坎医学院 |
流感病毒血细胞凝集素蛋白及其用途
|
KR102389489B1
(ko)
|
2016-06-16 |
2022-04-22 |
얀센 백신스 앤드 프리벤션 비.브이. |
Hiv 백신 제형
|
US10307477B2
(en)
|
2016-09-02 |
2019-06-04 |
Janssen Vaccines & Prevention B.V. |
Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment
|
BR112019004593A2
(pt)
|
2016-09-15 |
2019-07-02 |
Janssen Vaccines & Prevention Bv |
mutações da proteína do envelope do hiv estabilizando o trímero
|
EA201990719A1
(ru)
|
2016-09-20 |
2019-10-31 |
|
Новые промоторы
|
UY37406A
(es)
|
2016-09-20 |
2018-03-23 |
Boehringer Ingelheim Vetmedica Gmbh |
Nuevo sitio de inserción orf70 de ehv
|
KR102566066B1
(ko)
|
2016-09-20 |
2023-08-16 |
베링거잉겔하임베트메디카게엠베하 |
신규한 돼지 인플루엔자 백신
|
TW201823467A
(zh)
|
2016-09-20 |
2018-07-01 |
德商百靈佳殷格翰維美迪加股份有限公司 |
犬腺病毒載體
|
WO2018069316A2
(en)
|
2016-10-10 |
2018-04-19 |
Transgene Sa |
Immunotherapeutic product and mdsc modulator combination therapy
|
US11230572B2
(en)
|
2016-10-17 |
2022-01-25 |
Beth Israel Deaconess Medical Center, Inc. |
Signature-based human immunodeficiency virus (HIV) envelope (Env) trimer vaccines and methods of using the same
|
US10660952B2
(en)
|
2016-11-03 |
2020-05-26 |
Boehringer Ingelheim Vetmedica Gmbh |
Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof
|
UA127859C2
(uk)
|
2016-11-03 |
2024-01-31 |
Бьорінгер Інгельхайм Ветмедіка Гмбх |
Вакцина проти свинячого парвовірусу
|
JP7078620B2
(ja)
|
2016-11-16 |
2022-05-31 |
イミュノミック セラピューティックス, インコーポレイテッド |
アレルギーの治療のための核酸
|
US11549149B2
(en)
|
2017-01-24 |
2023-01-10 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
EP3573655A2
(de)
|
2017-01-30 |
2019-12-04 |
Boehringer Ingelheim Animal Health USA Inc. |
Impfstoffe gegen porzines coronavirus
|
US11254733B2
(en)
|
2017-04-07 |
2022-02-22 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza B virus neuraminidase antibodies and uses thereof
|
WO2018195527A1
(en)
|
2017-04-22 |
2018-10-25 |
Immunomic Therapeutics, Inc. |
Improved lamp constructs
|
CA3061950A1
(en)
|
2017-05-02 |
2018-11-08 |
Immunomic Therapeutics, Inc. |
Lamp (lysosomal associated membrane protein) constructs comprising cancer antigens
|
EP3638302B1
(de)
|
2017-06-15 |
2024-03-13 |
Janssen Vaccines & Prevention B.V. |
Hiv-antigene codierende pockenvirusvektoren und verfahren zu deren verwendung
|
KR20240113607A
(ko)
|
2017-06-21 |
2024-07-22 |
트랜스진 |
개인 맞춤형 백신
|
PE20200613A1
(es)
|
2017-07-11 |
2020-03-11 |
Pfizer |
Composiciones inmunogenicas
|
BR112020000711A2
(pt)
|
2017-07-12 |
2020-07-14 |
Boehringer Ingelheim Animal Health USA Inc. |
composições imunogênicas de senecavírus a e métodos destas
|
WO2019016062A1
(en)
|
2017-07-19 |
2019-01-24 |
Janssen Vaccines & Prevention B.V. |
HIV ENVELOPE PROTEIN MUTATIONS STABILIZING TRIMERIC FORM
|
KR20200041897A
(ko)
|
2017-08-01 |
2020-04-22 |
에이비 스튜디오 인코포레이티드 |
이중특이 항체 및 그의 용도
|
US11311612B2
(en)
|
2017-09-19 |
2022-04-26 |
Geovax, Inc. |
Compositions and methods for generating an immune response to treat or prevent malaria
|
EP3684812A4
(de)
|
2017-09-21 |
2021-09-08 |
Eucure (Beijing) Biopharma Co., Ltd |
Anti-ctla4-antikörper und verwendungen davon
|
UY37889A
(es)
|
2017-09-23 |
2019-03-29 |
Boehringer Ingelheim Vetmedica Gmbh |
Sistema de expresión de paramyxoviridade, antígenos y composiciones inmunogénicas
|
WO2019092027A1
(en)
|
2017-11-09 |
2019-05-16 |
Boehringer Ingelheim Vetmedica Gmbh |
Sapelovirus immunogenic compositions and uses thereof
|
US10864263B2
(en)
|
2017-11-20 |
2020-12-15 |
Janssen Pharmaceuticals, Inc. |
Method of providing safe administration of adenoviral vectors encoding a zika virus antigen
|
SG11202003443TA
(en)
|
2017-11-24 |
2020-05-28 |
Eucure Beijing Biopharma Co Ltd |
Anti-ox40 antibodies and uses thereof
|
WO2019165114A1
(en)
|
2018-02-21 |
2019-08-29 |
The University Of Montana |
Diaryl trehalose compounds and uses thereof
|
EA202091958A1
(ru)
|
2018-02-23 |
2021-02-04 |
Бёрингер Ингельхайм Ветмедика Гмбх |
Рекомбинантные вирусные векторные системы, экпрессирующие экзогенные гены кошачьего парамиксовируса, и вакцины, приготовленные из них
|
KR102608723B1
(ko)
|
2018-02-23 |
2023-12-01 |
유큐(베이징) 바이오파마 코., 엘티디 |
항―pd-1 항체 및 그의 용도
|
US11572381B2
(en)
|
2018-03-02 |
2023-02-07 |
The University Of Montana |
Immunogenic trehalose compounds and uses thereof
|
JP7245260B2
(ja)
|
2018-03-19 |
2023-03-23 |
ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー |
Ehv挿入部位ul43
|
US11384365B2
(en)
|
2018-03-19 |
2022-07-12 |
Boehringer Ingelheim Vetmedica Gmbh |
EHV with inactivated UL18 and/or UL8
|
US11957746B2
(en)
|
2018-03-26 |
2024-04-16 |
Boehringer Ingelheim Animal Health USA Inc. |
Method of producing an immunogenic composition
|
JP2021523185A
(ja)
|
2018-05-15 |
2021-09-02 |
イミュノミック セラピューティックス, インコーポレイテッドImmunomic Therapeutics, Inc. |
アレルゲンを含む改善されたlamp構築物
|
SG11202100510PA
(en)
|
2018-07-20 |
2021-02-25 |
Eucure Beijing Biopharma Co Ltd |
Anti-cd40 antibodies and uses thereof
|
MX2021002750A
(es)
|
2018-09-12 |
2021-05-12 |
Eucure Beijing Biopharma Co Ltd |
Anticuerpos anti-tnfrsf9 y usos de los mismos.
|
WO2020058341A1
(en)
|
2018-09-20 |
2020-03-26 |
Boehringer Ingelheim Vetmedica Gmbh |
Intranasal vector vaccine against porcine epidemic diarrhea
|
KR20210062015A
(ko)
|
2018-09-20 |
2021-05-28 |
베링거잉겔하임베트메디카게엠베하 |
변형된 pedv 스파이크 단백질
|
US20210382068A1
(en)
|
2018-10-02 |
2021-12-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
JP7469305B2
(ja)
|
2018-11-19 |
2024-04-16 |
バイオサイトジェン ファーマシューティカルズ (ベイジン) カンパニー リミテッド |
抗pd-1抗体およびその使用
|
WO2020131586A2
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|
BR112021013507A2
(pt)
|
2019-01-10 |
2021-11-16 |
Janssen Biotech Inc |
Neoantígenos da próstata e seus usos
|
CA3125380A1
(en)
|
2019-02-18 |
2020-08-27 |
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. |
Genetically modified non-human animals with humanized immunoglobulin locus
|
SG11202112870WA
(en)
|
2019-05-23 |
2021-12-30 |
The Univ Of Montana |
Vaccine adjuvants based on tlr receptor ligands
|
US20240108703A1
(en)
|
2019-10-18 |
2024-04-04 |
Immunomic Therapeutics, Inc. |
Improved LAMP Constructs Comprising Cancer Antigens
|
BR112022009598A2
(pt)
|
2019-11-18 |
2022-08-16 |
Janssen Biotech Inc |
Vacinas baseadas em calr e jak2 mutantes e uso dos mesmos
|
EP3842065A1
(de)
|
2019-12-23 |
2021-06-30 |
Transgene |
Verfahren zum entwurf eines rekombinanten pockenvirus für einen therapeutischen impfstoff
|
CN116096732A
(zh)
|
2020-01-31 |
2023-05-09 |
贝斯以色列护理医疗中心有限公司 |
用于预防和治疗冠状病毒感染的组合物和方法-sars-cov-2疫苗
|
WO2021158878A1
(en)
|
2020-02-06 |
2021-08-12 |
Boehringer Ingelheim Animal Health USA Inc. |
Polypeptides useful for detecting anti-rhabdovirus antibodies
|
TW202144389A
(zh)
|
2020-02-14 |
2021-12-01 |
美商健生生物科技公司 |
在多發性骨髓瘤中表現之新抗原及其用途
|
TW202144388A
(zh)
|
2020-02-14 |
2021-12-01 |
美商健生生物科技公司 |
在卵巢癌中表現之新抗原及其用途
|
WO2021178591A1
(en)
|
2020-03-04 |
2021-09-10 |
Bioeclipse Therapeutics, Inc. |
Methods of manufacturing activated immune cells
|
WO2021209897A1
(en)
|
2020-04-13 |
2021-10-21 |
Janssen Biotech, Inc. |
Psma and steap1 vaccines and their uses
|
KR20230018439A
(ko)
|
2020-06-02 |
2023-02-07 |
바이오사이토젠 파마슈티컬스 (베이징) 컴퍼니 리미티드 |
공동 경쇄 면역글로불린 좌위를 갖는 유전자 변형 비인간 동물
|
US20230029453A1
(en)
|
2020-07-06 |
2023-02-02 |
Janssen Biotech, Inc. |
Prostate Neoantigens And Their Uses
|
WO2022009049A1
(en)
|
2020-07-06 |
2022-01-13 |
Janssen Biotech, Inc. |
Prostate neoantigens and their uses
|
US20230035403A1
(en)
|
2020-07-06 |
2023-02-02 |
Janssen Biotech, Inc. |
Method For Determining Responsiveness To Prostate Cancer Treatment
|
JP2023544403A
(ja)
|
2020-10-05 |
2023-10-23 |
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド |
サーコウイルス科カプシドタンパク質を含む融合タンパク質、及びそれから構成されるキメラウイルス様粒子
|
CN116438195A
(zh)
|
2020-10-05 |
2023-07-14 |
勃林格殷格翰动物保健有限公司 |
用于针对轮状病毒疫苗接种的融合蛋白质
|
WO2023077147A2
(en)
|
2021-11-01 |
2023-05-04 |
Pellis Therapeutics, Inc. |
T-cell vaccines for patients with reduced humoral immunity
|
WO2023194913A1
(en)
|
2022-04-05 |
2023-10-12 |
Boehringer Ingelheim Vetmedica Gmbh |
Immunogenic composition useful for vaccination against rotavirus
|
WO2023201201A1
(en)
|
2022-04-10 |
2023-10-19 |
Immunomic Therapeutics, Inc. |
Bicistronic lamp constructs comprising immune response enhancing genes and methods of use thereof
|
WO2023213763A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
|
WO2023213764A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
|
WO2024011250A1
(en)
|
2022-07-08 |
2024-01-11 |
Viromissile, Inc. |
Oncolytic vaccinia viruses and recombinant viruses and methods of use thereof
|
WO2024015892A1
(en)
|
2022-07-13 |
2024-01-18 |
The Broad Institute, Inc. |
Hla-ii immunopeptidome methods and systems for antigen discovery
|